NATCOPHARM.BONATCOPHARM.BOBSE
Loading
Year-over-year revenue growth rate
Percentile
P5
Near historical low
vs 3Y Ago
-3.8x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -52.51% |
| Q3 2025 | 2.57% |
| Q2 2025 | 8.62% |
| Q1 2025 | 157.67% |
| Q4 2024 | -65.37% |
| Q3 2024 | 0.62% |
| Q2 2024 | 27.17% |
| Q1 2024 | 41.25% |
| Q4 2023 | -26.45% |
| Q3 2023 | -9.57% |
| Q2 2023 | 26.82% |
| Q1 2023 | 82.60% |
| Q4 2022 | 13.98% |
| Q3 2022 | -51.15% |
| Q2 2022 | 47.88% |
| Q1 2022 | 6.73% |
| Q4 2021 | 48.59% |
| Q3 2021 | -8.07% |
| Q2 2021 | 22.37% |
| Q1 2021 | -5.60% |
| Q4 2020 | -55.72% |
| Q3 2020 | 42.39% |
| Q2 2020 | 23.88% |
| Q1 2020 | -5.68% |
| Q4 2019 | -0.72% |
| Q3 2019 | -1.34% |
| Q2 2019 | 8.03% |
| Q1 2019 | -18.14% |
| Q4 2018 | 2.43% |
| Q3 2018 | 0.91% |
| Q2 2018 | -29.85% |
| Q1 2018 | 36.57% |
| Q4 2017 | 31.76% |
| Q3 2017 | -0.33% |
| Q2 2017 | -19.68% |
| Q1 2017 | -21.50% |
| Q4 2016 | 47.52% |
| Q3 2016 | 41.53% |
| Q2 2016 | 5.71% |
| Q1 2016 | 11.45% |